India-based Himalaya Drug Company is all set to launch a Global Research Centre in one of the Dubai Science Park’s new built-to-suit units.
Himalaya produces over 300 cosmetics, nutritional supplements, herbal medicines and pharmaceutical-grade Ayurvedic products in over 90 countries. Set to launch in 2021, the modern facility aims to enhance Himalaya’s R&D capabilities at Dubai Science Park (DSP) to serve the GCC region.
Himalaya’s core business lies in R&D and manufacturing of high-quality pharmaceutical and personal care products for health-conscious consumers. The Himalaya Global Research Centre (HGRC) has been part of DSP’s eco-friendly Laboratory Complex since 2013, with product development, quality control and standardisation serving as priority areas of focus for the new facility.
“In line with our ambition to consolidate Dubai’s position as a prime destination for scientific, R&D and manufacturing activities, we are pleased to support the expansion of Himalaya. Its a company dedicated to enhancing its expertise in the pharmaceutical and personal care fields,” says Marwan Abdulaziz Janahi, managing director of DSP and chairing member of the Pharmaceuticals and Medical Equipment Taskforce of the Dubai Industrial Strategy 2030.
“We aim to establish Himalaya as a science-based, problem solving, head to heel brand, not only within Dubai but within the wider GCC region and surrounding international markets. Himalaya invests in markets with an in-depth and long-term approach, maintaining high ethical standards at each step of the way. The UAE is a perfect place for us to initiate this expansion,” says Meraj Manal, chairman, Himalaya Global Holdings.
“Himalaya is firmly committed to upholding high ethical standards of research. Dubai’s capacity to attract skilled and talented people will enable the new HGRC complex to evolve into a global think tank,” adds Neil Cabral, executive director of Himalaya Global LTD.